5 billion people have access to medicine
2 billion to go

The Access to Medicine Foundation stimulates and guides pharmaceutical companies to do more for the people living in low- and middle-income countries without access to medicine.

Quick access

Our research programmes

Access to
Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Visit this programme

Antimicrobial
Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Visit this programme

Access to
Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.

Visit this programme

View all news

Publication - 09 Jun 2020

Progress against HIV, malaria and TB is under threat, putting children at risk. Here’s what is needed.

COVID-19 and drug resistance are threatening to derail the progress made against the HIV, malaria and TB epidemics. This new series assesses the current situation for each of the three diseases and how to end their burden on children.

View all publications

Event - 25 Oct 2020

2020 World Health Summit

The 2020 World Health Summit will take place from October 25-27. The conference, held in Berlin, will also be held digitally in light of the COVID-19 pandemic. Jayasree K. Iyer will join digitally to speak at three workshops.

View upcoming events

What leaders say

"The Access to Medicine Index is a very important project. What gets measured, gets done."

Dr. Margaret Chan

Former Director General, World Health Organisation

"I’ve been impressed by the Access to Medicine Index. It presents well-balanced stakeholder views on good practices for the pharmaceutical industry and it provides clear standards against which the performance of individual companies can be judged."

Mary Robinson

President, Realizing Rights, Former UN High Commissioner for Human Rights (1997-2002), Former President of Ireland (1990-1997)

"When I talk to executives from pharmaceutical companies they tell me that they want to do more for neglected diseases, but they at least need to get credit for it. The Access to Medicine Index does exactly that."